Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data
Chuanhui Xu, Zixi Yi, Ruyi Cai, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 4, pp. 102778-102778
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis
Richard Conway, Alyssa Grimshaw, Maximilian F. Konig, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 5, pp. 766-775
Open Access | Times Cited: 158
COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey
Priyanka Gaur, Hardik Agrawat, Anuj Shukla
Rheumatology International (2021) Vol. 41, Iss. 9, pp. 1601-1605
Open Access | Times Cited: 81
Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions
Marco Krasselt, Ulf Wagner, Phuong Nguyen, et al.
Lara D. Veeken (2022) Vol. 61, Iss. SI2, pp. SI180-SI188
Open Access | Times Cited: 47
Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system
Qi Wei, Philip J. Mease, Michael Chiorean, et al.
The Lancet Digital Health (2024) Vol. 6, Iss. 5, pp. e309-e322
Open Access | Times Cited: 5
Recommendations for COVID‐19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists
Amelia Santosa, Chuanhui Xu, Thaschawee Arkachaisri, et al.
International Journal of Rheumatic Diseases (2021) Vol. 24, Iss. 6, pp. 746-757
Open Access | Times Cited: 34
COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis
René Cordtz, Salome Kristensen, Rasmus Westermann, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 1, pp. 77-88
Open Access | Times Cited: 26
Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis
Feier Wang, Yubo Ma, Shanshan Xu, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 7, pp. 2213-2223
Open Access | Times Cited: 25
Impact of Immunomodulatory Therapy on COVID-19 Vaccine Response in Patients with Autoimmune Inflammatory Rheumatic Diseases
Ruth Xian Lynn Yap, Yi Wye Lai, Chang Wei, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 274-274
Open Access | Times Cited: 4
COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review
Athanasios‐Dimitrios Bakasis, Clio P. Mavragani, Kyriaki Boki, et al.
Journal of Autoimmunity (2021) Vol. 123, pp. 102687-102687
Open Access | Times Cited: 30
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network
Rahul Raiker, Haig Pakhchanian, Charles DeYoung, et al.
Journal of Autoimmunity (2021) Vol. 125, pp. 102730-102730
Open Access | Times Cited: 29
Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study
Valeria Belleudi, Alessandro Cesare Rosa, Francesca Romana Poggi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2388-2388
Open Access | Times Cited: 23
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING)
Margaret Ma, Amelia Santosa, Warren Fong, et al.
Journal of Autoimmunity (2022) Vol. 134, pp. 102959-102959
Open Access | Times Cited: 17
COVID-19 Mortality in Patients with Rheumatic Diseases: A Real Concern
Nasra Al Adhoubi, Maha Ali, Humaid Al Wahshi, et al.
Current Rheumatology Reviews (2022) Vol. 18, Iss. 3, pp. 234-242
Closed Access | Times Cited: 15
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
Leonardo Santos Hoff, R Naveen, Samuel Katsuyuki Shinjo, et al.
Rheumatology International (2022) Vol. 43, Iss. 1, pp. 47-58
Open Access | Times Cited: 15
A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations
Fadi Kharouf, Tali Eviatar, Maya Braun, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study
Warren Fong, Ting Hui Woon, Li‐Ching Chew, et al.
Advances in Rheumatology (2023) Vol. 63, Iss. 1
Open Access | Times Cited: 7
Association between previous rheumatoid arthritis and COVID-19 and its severity: a nationwide cohort study in South Korea
Younghee Jung, Mi‐Hye Kwon, Hyo Geun Choi
BMJ Open (2021) Vol. 11, Iss. 10, pp. e054753-e054753
Open Access | Times Cited: 14
The Recent Outbreak of COVID-19 in China During the Omicron Variant Predominance: Clinical Features and Outcomes in Patients with Autoimmune Inflammatory Rheumatic Diseases
Yan Geng, Yong Fan, Xuerong Deng, et al.
Rheumatology and Therapy (2023) Vol. 10, Iss. 4, pp. 1039-1053
Open Access | Times Cited: 5
The impact of COVID-19 on familial Mediterranean fever: a nationwide study
Zafer Günendi, Fatma Gül Yurdakul, Hatice Bodur, et al.
Rheumatology International (2021) Vol. 41, Iss. 8, pp. 1447-1455
Open Access | Times Cited: 13
Attitudes toward COVID-19 Vaccination: A Survey of Chinese Patients with Rheumatic Diseases
Zixi Yi, Zhongqiang Yao, Dan Xu, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1604-1604
Open Access | Times Cited: 9
Look after the COVID‐19 pandemic: Mortality rates among patients with rheumatic diseases
Ezgi Çimen Güneş, Seda Çolak, Zeynep Belma ŞENLİK, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 3
Closed Access | Times Cited: 1
Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up
Rocío V. Gamboa‐Cárdenas, Silvia Barzola-Cerrón, Denisse Toledo-Neira, et al.
Clinical Rheumatology (2021) Vol. 40, Iss. 11, pp. 4725-4734
Open Access | Times Cited: 12
A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases
Abhishek Patil, K Chanakya, Padmanabha Shenoy, et al.
BMC Rheumatology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 8
The Course of COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases
Marta Rorat, Dorota Zarębska‐Michaluk, Justyna D. Kowalska, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7342-7342
Open Access | Times Cited: 8
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines
Andrea Picchianti Diamanti, Maria Manuela Rosado, Emanuele Nicastri, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top